Cavalla david (17 Ergebnisse)

Paperback. Zustand: Very Good. The book has been read, but is in excellent condition. Pages are intact and not marred by notes or highlighting. The spine remains undamaged.

Hardback. Zustand: As New. x 218p hardback, blue and grey cover, like new condition, little to no wear, binding tight, pages clean and bright like new, author's signature on the front endpaper Language: English.

HRD. Zustand: New. New Book. Shipped from UK. Established seller since 2000.

Zustand: New. In.

Buch. Zustand: Neu. Neuware - Today's medicines are regulated for their efficacy and safety and, once approved, they can be marketed for certain uses as justified by the data. Regulatory bodies in developed countries are constituted by legal statute and operate as parts of government, ostensibly in the interests of the people as patients.But once approved, medicines can be used for any purpose the prescriber thinks fit and appropriate for the patient. One in five prescriptions is therefore written outside regulatory purview.Off-label Prescribing looks into the corners of our medicated lives, where drug regulation runs up against medical practice, and concerns the use of a drug that has been approved for one use (in medical parlance, 'indication') being used for a different indication; alternatively, being used on a different set of patients from the ones it is approved for, or at a different dose. Usually the patient is unaware of what is going on, having not been informed by their doctor of this aspect of his or her prescribing choice.The book examines how and why this occurs, what the various medical professions have to say about it, and how pharmaceutical companies benefit by moving into this poorly regulated area. Off-label Prescribing pulls these complex issues together in one volume, to highlight current practice, its advantages and weaknesses and how the author suggests practice should evolve in the future. It will therefore be of interest to all those who prescribe (and receive) medicines, combined with a greater objective to provide more transparency and discussion for professionals.…

HRD. Zustand: New. New Book. Shipped from UK. Established seller since 2000.

HRD. Zustand: New. New Book. Shipped from UK. Established seller since 2000.

Zustand: New. pp. 228.

HRD. Zustand: New. New Book. Shipped from UK. Established seller since 2000.

Zustand: New. In English.

Zustand: New. In English.

Zustand: New. Drug Repurposing provides an ideal introduction to the field of drug repositioning and repurposing with contributions from world-renowned experts culminating in an excellent resource for any drug discovery or medicinal chemist.Klappentextrnr.

Hardcover. Zustand: Brand New. gld edition. 400 pages. 9.21x6.14x1.00 inches. In Stock.

Buch. Zustand: Neu. Neuware - Drug Repurposing is the development of existing drugs for new uses: given that 9 in 10 drugs that enter drug development are never marketed and therefore represent wasted effort, it is an attractive as well as inherently more efficient process. Three repurposed drugs can be brought to market for the same cost as one new chemical entity; and they can also be identified more quickly, an important benefit for patients whose diseases are progressing faster than therapeutic innovation. This book provides a single source, comprehensive reference on the latest developments and innovations in drug repurposing ideal for students and researchers in pharmaceutical science and drug discovery.…

Hardcover. Zustand: Brand New. 1st edition. 218 pages. 9.00x6.25x0.75 inches. In Stock.

Zustand: New. The emphasis on cost-effectiveness within the pharmaceutical industry has caused it to outsource some development work. This text addresses the advantages and disadvantages of collaborations between industrial research and development divisions and contract research organizations and universities. Num Pages: 228 pages, Ill. BIC Classification: KNDP; MBGR; TDCW. Category: (P) Professional & Vocational; (UP) Postgraduate, Research & Scholarly. Dimension: 242 x 165 x 18. Weight in Grams: 488. . 1997. 1st Edition. Hardcover. . . . . Books ship from the US and Ireland.…

58 pp.; 27 x 26.9 cm.; staple bound; black-and-white & color; edition size unknown; unsigned and unnumbered; offset-printed; Issue edited by Philip Leider. Essays "Culture & Subsidy: A Report on the U.C.L.A. Arts Convention," by Keith Boyle; "Emil Nolde," by Alfred Werner; "Three San Francisco Artists," by James Monte; "Four Drawings," by John Hultberg; "Are We Getting Anywhere?" by Henry Miller; "Marcel Cavalla," by Rosalind G. Wholden "Review and Response," by Don Factor and Howard Warshaw. Reviews by Fidel A. Danieli, Irma E. Desenberg, Don Factor, Joan Hugo, Jorgen L. Hansen, George R. James, Doug McClellan, Constance Perkins, Shirley Y. Pettibone, Donald Totten, Harriette von Breton, Rosalind G. Wholden, H.J. Weeks, David Gebhard, Delores Yonker. Cover: Emil Nolde, "Dancer," 1913. Good. Rubbing of covers and bumping of corners. Wrinkling on bottom left corner of verso and 4 cm. dog ear on top left corner of verso. Contents clean and unmarked.…